Published

Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: EClinicalMedicine
Date: 2020-10-01
Source: PubMed
DOI: 10.1016/j.eclinm.2020.100538
PubMed: 33150319

Authors

Anderson BT Danforth A Daroff PR Stauffer C Ekman E Agin-Liebes G Trope A Boden MT Dilley PJ Mitchell J Woolley J

Watch author

Derived topics and classifications

psilocybin Depression Anxiety Veterans Safety Adverse Events Other

Citation graph

0 referenced DOIs found in stored source metadata. 11 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Mindfulness-Based Psilocybin-Assisted Therapy (MB-PAT) for cancer-related demoralization in Canada: The case for a hybrid group-based delivery model2026-12-01 Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depression2026-11-01 Safety, feasibility, and preliminary clinical outcomes of psilocybin-assisted therapy for veterans with severe, treatment-resistant PTSD: an open-label pilot clinical trial2026-07-30 Learnings from a hybrid communities of practice group therapy model to support psilocybin-assisted therapy for patients with a terminal diagnosis2026-07-20 Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research Directions2026-07-02 Community engagement as a foundation for implementation research for group psilocybin assisted therapy in New Mexico2026-06-17 Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations2026-06-01 Effect of psilocybin-assisted psychotherapy on anxiety symptoms: A systematic review and meta-analysis2026-05-29 Psilocybin in the Treatment of Cocaine Use Disorder2026-05-07 Advancing cancer neuroscience through stress modulation: Interdisciplinary potential of psilocybin and ketamine2026-05-01 Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study.2020-10-01

Related papers

Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced Stage Cancer: a Pilot StudyClinicalTrials.gov · 2026-03-18 Pragmatic Trial of Psilocybin Therapy in Palliative Care (PT2PC): A Multicenter Triple-blind Phase 2 Randomized Controlled Trial of Psilocybin Therapy for Demoralized Adults Near the End of LifeClinicalTrials.gov · 2025-11-25 Lysergic Acid Diethylamide (LSD) in Palliative Care: a Randomised, Double-blind, Active-placebo Controlled Phase II Study (LPC-Study)ClinicalTrials.gov · 2026-04-29 Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care - PATH StudyClinicalTrials.gov · 2026-02-17 Exploratory Study of the Effects of Low-Dose Psilocybin on Sensory Processing, Neurophysiological Arousal, and Emotional HealthClinicalTrials.gov · 2026-03-11